Collegium Pharmaceutical, Inc. (COLL)

Collegium Pharmaceutical Revenue

Collegium Pharmaceutical had revenue of $188.00M in the quarter ending June 30, 2025, with 29.41% growth. This brings the company's revenue in the last twelve months to $707.01M, up 22.61% year-over-year. In the year 2024, Collegium Pharmaceutical had annual revenue of $631.45M with 11.41% growth.

• Revenue (ttm): $707.01M
• Revenue Growth: +22.61%
• P/S Ratio: 1.71
• Revenue / Employee: $1,980,412
• Employees: 357
• Market Cap: 1.16B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	631.45M	64.68M	11.41%
Dec 31, 2023	566.77M	102.83M	22.17%
Dec 31, 2022	463.93M	187.07M	67.56%
Dec 31, 2021	276.87M	-33.15M	-10.69%
Dec 31, 2020	310.02M	13.32M	4.49%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.